Literature DB >> 35307946

Erratum.

.   

Abstract

Entities:  

Year:  2022        PMID： 35307946      PMCID： PMC9394623          DOI： 10.1111/jth.15679

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   16.036


× No keyword cloud information.
  1 in total

1.  Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.

Authors:  Pancras C Wong; Earl J Crain; Jeffrey M Bozarth; Yiming Wu; Andrew K Dilger; Ruth R Wexler; William R Ewing; David Gordon; Joseph M Luettgen
Journal:  J Thromb Haemost       Date:  2021-11-24       Impact factor: 16.036
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.